APIM Therapeutics AS
PrivateLast Round
Private Equity
May 18, 2021
Total Funding Raised
$540,000
Company Overview
APIM Therapeutics AS operates in Healthcare & Life Sciences and is based in Trondheim. Its latest recorded funding round was a Private Equity round in May 2021.
APIM Therapeutics AS is a biotechnology company that develops first-in-class peptide therapeutics targeting PCNA to disrupt cellular stress responses and overcome cancer treatment resistance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
APIM Therapeutics AS Comparables
Compare APIM Therapeutics AS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RLL, LLC | 83% | |
| FoRx Therapeutics | 71% | |
| Artios Pharma | 66% |
For institutional investors. Book with your work email.
APIM Therapeutics AS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | May 18, 2021 | ||||
| VC Round | Dec 1, 2017 | ||||
| VC Round | Oct 17, 2012 | ||||
| Seed | Nov 10, 2011 | ||||
| Seed | Mar 21, 2011 | ||||
Seed | May 27, 2010 |
For institutional investors. Book with your work email.
APIM Therapeutics AS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Birk Venture | VC Round, Seed |
| Investinor | VC Round |
| Trond Mohn Research Foundation | VC Round |
| Sarsia Seed | Seed |
| Sarsia | Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2026
Monthly visitors grew 95% MoM.
- Jan 9, 2026
Monthly visitors grew 123% MoM, reaching 984.
For institutional investors. Book with your work email.
APIM Therapeutics AS Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about APIM Therapeutics AS's valuation, stock price, and market status.
Is APIM Therapeutics AS a public or private company?
APIM Therapeutics AS is a private company.
What is the current stock price of APIM Therapeutics AS?
APIM Therapeutics AS is a private company, so its shares have no public market price. Caplight tracks APIM Therapeutics AS's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is APIM Therapeutics AS worth (valuation)?
Valuation information for APIM Therapeutics AS is not publicly available.
Can I buy APIM Therapeutics AS stock?
APIM Therapeutics AS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was APIM Therapeutics AS's last funding round?
APIM Therapeutics AS's most recent funding round was Private Equity on May 18, 2021.
Who are the main investors in APIM Therapeutics AS?
Key investors in APIM Therapeutics AS include Birk Venture, Sarsia Seed.
Will APIM Therapeutics AS IPO soon?
No public IPO plans have been announced for APIM Therapeutics AS.
How can I track APIM Therapeutics AS secondary market activity?
Caplight tracks bids, offers, and trades in APIM Therapeutics AS's shares on secondary markets.